Eiko Lifesciences Ltd vs Prolife Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 52.4 as of 20 Mar 15:30 . The P/E Ratio of Eiko Lifesciences Ltd is 31.1 as of March 2025 .The P/E Ratio of Prolife Industries Ltd is 0 as of March 2025 . The Market Cap of Eiko Lifesciences Ltd is ₹ 65.15 crore as of March 2025 .The Market Cap of Prolife Industries Ltd is ₹ 0 crore as of March 2025 . The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of Prolife Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of Prolife Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of Prolife Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Prolife Industries Ltd changed from 2.23 % on March 2021 to 2.62 % on March 2025 . This represents a CAGR of 3.28% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About Prolife Industries Ltd

Prolife Industries Limited was incorporated at Ankleshwar as 'Mamta Dyes and Intermediates Private Limited' on July 27, 1994 with the Registrar of Companies at Gujarat, Dadra & Nagar Haveli.
The status of the Company was converted into Public Company.
The name of the Company was changed from Mamta Dyes and Intermediates Limited to 'R.R.J. Dyes and Intermediates Limited' dated February 20, 1997 and later on was changed to 'Prolife Industries Limited' vide fresh Certificate of Incorporation dated March 7, 2013. The Company made a public issue of 11,10,000 Equity Shares by raising capital aggregating to Rs. 4.2 Crore in December, 2016. The Company is engaged in the business of manufacturing special and exclusive range of intermediates for dyes, pigments, agrochemicals and others.
The main end product of the company is Naphthalene based Dyes & Intermediates which are being sold to well known multinational trading houses in various countries like U.

FAQs for the comparison of Eiko Lifesciences Ltd and Prolife Industries Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or Prolife Industries Ltd?

Market cap of Eiko Lifesciences Ltd is 75 Cr while Market cap of Prolife Industries Ltd is 23 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and Prolife Industries Ltd?

The stock performance of Eiko Lifesciences Ltd and Prolife Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and Prolife Industries Ltd?

As of March 23, 2026, the Eiko Lifesciences Ltd stock price is INR ₹52.4. On the other hand, Prolife Industries Ltd stock price is INR ₹58.4.

How do dividend payouts of Eiko Lifesciences Ltd and Prolife Industries Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and Prolife Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.